Pharmacokinetics, Pharmacodynamics, Safety, and Preliminary Efficacy of Subcutaneous Injection of SHR-1905 in Adolescent Asthmatic Subjects - an Open-label, Single-dose Phase II Clinical Study

Phase 2 Completed 9 enrolled Guangdong Hengrui Pharmaceutical Co., Ltd

NaSingle-groupOpen-labelTreatment

Summary

Pharmacokinetics, pharmacodynamics, safety, and preliminary efficacy of subcutaneous injection of SHR-1905 in adolescent asthmatic subjects - an open-label, single-dose Phase II clinical study

Timeline

Start: 2025-01-23
Primary completion: 2025-12-03
Completion: 2025-12-03

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	SHR-1905	Monoclonal antibody	—	Subcutaneous

Pharmacokinetics, Pharmacodynamics, Safety, and Preliminary Efficacy of Subcutaneous Injection of SHR-1905 in Adolescent Asthmatic Subjects - an Open-label, Single-dose Phase II Clinical Study

Summary

Timeline

Drugs

Indications